Allworth Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.9K | Buy |
2,007
+251
| +14% | +$6.11K | ﹤0.01% | 1950 |
|
|
2025
Q1 | $39.4K | Sell |
1,756
-315
| -15% | -$7.07K | ﹤0.01% | 1665 |
|
|
2024
Q4 | $56.2K | Buy |
2,071
+118
| +6% | +$3.2K | ﹤0.01% | 1517 |
|
|
2024
Q3 | $50K | Hold |
1,953
| – | – | ﹤0.01% | 1405 |
|
|
2024
Q2 | $49.6K | Sell |
1,953
-602
| -24% | -$15.3K | ﹤0.01% | 1393 |
|
|
2024
Q1 | $73.5K | Buy |
2,555
+1,659
| +185% | +$47.7K | ﹤0.01% | 1131 |
|
|
2023
Q4 | $29.4K | Sell |
896
-529
| -37% | -$17.3K | ﹤0.01% | 1421 |
|
|
2023
Q3 | $39.7K | Buy |
1,425
+563
| +65% | +$15.7K | ﹤0.01% | 1207 |
|
|
2023
Q2 | $29.4K | Hold |
862
| – | – | ﹤0.01% | 1332 |
|
|
2023
Q1 | $25.9K | Buy |
862
+320
| +59% | +$9.63K | ﹤0.01% | 1309 |
|
|
2022
Q4 | $15.3K | Sell |
542
-51
| -9% | -$1.44K | ﹤0.01% | 1506 |
|
|
2022
Q3 | $19K | Hold |
593
| – | – | ﹤0.01% | 1302 |
|
|
2022
Q2 | $19K | Sell |
593
-11
| -2% | -$352 | ﹤0.01% | 1253 |
|
|
2022
Q1 | $28K | Sell |
604
-576
| -49% | -$26.7K | ﹤0.01% | 1099 |
|
|
2021
Q4 | $72K | Sell |
1,180
-178
| -13% | -$10.9K | ﹤0.01% | 758 |
|
|
2021
Q3 | $101K | Buy |
1,358
+806
| +146% | +$59.9K | ﹤0.01% | 613 |
|
|
2021
Q2 | $51K | Hold |
552
| – | – | ﹤0.01% | 608 |
|
|
2021
Q1 | $49K | Buy |
552
+460
| +500% | +$40.8K | ﹤0.01% | 578 |
|
|
2020
Q4 | $9K | Buy |
+92
| New | +$9K | ﹤0.01% | 855 |
|